Registrational phase 2 trial of sotorasib in KRAS p.G12C mutant NSCLC: First disclosure of the CodeBreaK 100 primary analysis Meeting Abstract


Authors: Li, B.; Skoulidis, F.; Falchook, G.; Sacher, A.; Velcheti, V.; Dy, G.; Price, T.; Borghaei, H.; Schuler, M.; Kato, T.; Takahashi, T.; Spira, A.; Ramalingam, S.; Besse, B.; Barlesi, F.; Tran, Q.; Henary, H.; Ngarmchamnanrith, G.; Govindan, R.; Wolf, J.
Abstract Title: Registrational phase 2 trial of sotorasib in KRAS p.G12C mutant NSCLC: First disclosure of the CodeBreaK 100 primary analysis
Meeting Title: 2020 World Conference on Lung Cancer
Keywords: nsclc; kras p.g12c; sotorasib (amg 510)
Journal Title: Journal of Thoracic Oncology
Volume: 16
Issue: 3 Suppl.
Meeting Dates: 2021 Jan 28-31
Meeting Location: Singapore
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2021-03-01
Start Page: S61
Language: English
ACCESSION: WOS:000631349600005
PROVIDER: wos
DOI: 10.1016/j.jtho.2021.01.321
Notes: Meeting Abstract: PS01.07 -- Due to Covid-19 pandemic, the conference was held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Bob Tingkan Li
    279 Li